{"id":178256,"date":"2023-12-14T03:23:59","date_gmt":"2023-12-14T09:23:59","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2023\/12\/scientists-uncover-mechanism-for-treating-dangerous-liver-condition"},"modified":"2023-12-14T03:23:59","modified_gmt":"2023-12-14T09:23:59","slug":"scientists-uncover-mechanism-for-treating-dangerous-liver-condition","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2023\/12\/scientists-uncover-mechanism-for-treating-dangerous-liver-condition","title":{"rendered":"Scientists Uncover Mechanism for Treating Dangerous Liver Condition"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/scientists-uncover-mechanism-for-treating-dangerous-liver-condition3.jpg\"><\/a><\/p>\n<p>A recent study conducted by <a href=\"https:\/\/scitechdaily.com\/tag\/oregon-state-university\/\">Oregon State University<\/a> has unveiled new insights into how certain polyunsaturated fatty acids, specifically omega 3, combat a severe liver condition. This discovery paves the way for novel drug research for nonalcoholic steatohepatitis (NASH), a disease currently without any FDA-approved treatments.<\/p>\n<p>Scientists led by Oregon State\u2019s Natalia Shulzhenko, Andrey Morgun and Donald Jump used a technique known as multi-omic network analysis to identify the mechanism through which dietary omega 3 supplements alleviated nonalcoholic steatohepatitis, usually abbreviated to NASH.<\/p>\n<p>The mechanism involves betacellulin, a protein growth factor that plays multiple positive roles in the body but also contributes to liver fibrosis, or scarring, and the progression to cirrhosis and liver cancer.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A recent study conducted by Oregon State University has unveiled new insights into how certain polyunsaturated fatty acids, specifically omega 3, combat a severe liver condition. This discovery paves the way for novel drug research for nonalcoholic steatohepatitis (NASH), a disease currently without any FDA-approved treatments. Scientists led by Oregon State\u2019s Natalia Shulzhenko, Andrey Morgun [\u2026]<\/p>\n","protected":false},"author":427,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-178256","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/178256","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/427"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=178256"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/178256\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=178256"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=178256"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=178256"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}